Zenith Drugs Limited Awarded Tender by Madhya Pradesh Public Health Services Corporation
Zenith Drugs Limited secured a Rs. 45,63,145 order from Madhya Pradesh Public Health Services Corporation for supplying 5,14,447 tubes of Mupirocin Ointment. The contract, awarded on May 05, 2026, is not a related party transaction and is expected to enhance operational performance.
*this image is generated using AI for illustrative purposes only.
zenith drugs has been awarded a significant tender by the Madhya Pradesh Public Health Services Corporation Limited. The announcement was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This order is viewed as a meaningful addition to the company's order book and reinforces its growing presence in the domestic pharmaceutical supply segment.
Contract Details
The contract pertains to the supply of a specific pharmaceutical product. The company has confirmed that this order has been awarded in the normal course of business and does not fall under related party transactions. Zenith Drugs remains committed to the timely execution of the order while maintaining high standards of quality and compliance.
Order Specifications
The specific details regarding the product and the financial value of the tender are outlined below:
| Specification | Details |
|---|---|
| Name of Entity | Madhya Pradesh Public Health Services Corporation Limited |
| Nature of Contract | Supply of Pharmaceutical Product |
| Product | Mupirocin Ointment (2% w/w, 5 gm tube) |
| Approximate Quantity | 5,14,447 tubes |
| Total Order Value | Rs. 45,63,145/- |
Strategic Impact
Management believes that this development will further strengthen the company's operational performance. The successful bid is expected to contribute positively to stakeholder value over the coming periods. The intimation was submitted to the National Stock Exchange of India Limited on May 05, 2026.
Historical Stock Returns for Zenith Drugs
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -3.05% | +8.32% | +4.88% | -30.73% | -47.72% | -59.15% |
How might Zenith Drugs leverage this government tender win to pursue larger state and central procurement contracts in the antibiotics and topical medications segment?
What impact could a sustained increase in government health procurement orders have on Zenith Drugs' revenue mix and profit margins over the next few fiscal years?
Could growing demand for generic topical antibiotics like Mupirocin from public health bodies signal broader opportunities for small-cap pharma companies in India's government procurement ecosystem?
20
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
